Clinical Trial Update: Study of Stapokibart Injection in Patients With Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Stapokibart Injection for allergic rhinitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Stapokibart Injection (Stapokibart)

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Allergic Rhinitis | Phase 2 | Status: RECRUITING